26:36

Genetic Models for CMT

22:01

Targeting SARM1 and Axon Degeneration as a Design-Modifying Strategy for the Treatment of CMT2A

35:15

Understanding CRISPR-Cas9

18:01

Anksiyete Bozukluğu Sandığın Aslında DEHB (ADHD) Olabilir!

25:11

ToPIC: Building a CMT Guidance Document for the FDA